Michael Milligan
Equibles does not estimate personal net worth.
Get an email with a short summary when Neumora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get NMRA alertsAbout Michael Milligan
Michael Milligan is recorded as CFO at Neumora Therapeutics, Inc. (NMRA). The newest filing on record that lists Michael Milligan as CFO at Neumora Therapeutics, Inc. (NMRA) is dated April 17, 2026. Neumora Therapeutics, Inc. reported in an 8-K filed February 13, 2025 that Michael Milligan was appointed Chief Financial Officer, effective February 14, 2025. Neumora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Neumora Therapeutics, Inc. includes Joshua Pinto (CEO and Board Member), Paul L. Berns (CEO, Chairman and Board Member), Bill Aurora (COO) and 7 others.
“Michael Milligan will serve as Chief Financial Officer in addition to his current role as principal accounting officer”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 17, 2026
Company network
Leadership on record at Neumora Therapeutics, Inc.
- Joshua Pinto CEO, Board Member
- Paul L. Berns CEO, Chairman, Board Member
- Bill Aurora COO
- Carol Suh COO
- Jason Duncan General Counsel
- Alaa Halawa Board Member
- David Piacquad Board Member
- Kristina Burow Board Member
- Matthew Fust Board Member
- Maykin Ho Board Member